Published in Antiviral Res on November 01, 2013
Current strategies for sustaining drug release from electrospun nanofibers. J Control Release (2015) 0.85
Electrospun solid dispersions of Maraviroc for rapid intravaginal preexposure prophylaxis of HIV. Antimicrob Agents Chemother (2014) 0.85
On-demand microbicide products: design matters. Drug Deliv Transl Res (2017) 0.84
Manufacturing scale-up of electrospun poly(vinyl alcohol) fibers containing tenofovir for vaginal drug delivery. Int J Pharm (2014) 0.81
The potential of HIV-1 nanotherapeutics: from in vitro studies to clinical trials. Nanomedicine (Lond) (2015) 0.76
Drug Delivery Approaches for the Treatment of Cervical Cancer. Pharmaceutics (2016) 0.75
Griffithsin-Modified Electrospun Fibers as a Delivery Scaffold to Prevent HIV Infection. Antimicrob Agents Chemother (2016) 0.75
Simultaneous measurement of etravirine, maraviroc and raltegravir in pigtail macaque plasma, vaginal secretions and vaginal tissue using a LC-MS/MS assay. J Chromatogr B Analyt Technol Biomed Life Sci (2016) 0.75
Rapidly Biodegrading PLGA-Polyurethane Fibers for Sustained Release of Physicochemically Diverse Drugs. ACS Biomater Sci Eng (2016) 0.75
Nanoparticle-releasing nanofiber composites for enhanced in vivo vaginal retention. Biomaterials (2017) 0.75
Two-dimensional paper networks: programmable fluidic disconnects for multi-step processes in shaped paper. Lab Chip (2011) 1.29
Drug-eluting fibers for HIV-1 inhibition and contraception. PLoS One (2012) 1.08
Cell-free protein synthesis with prokaryotic combined transcription-translation. Methods Mol Biol (2004) 0.93
Drug synergy of tenofovir and nanoparticle-based antiretrovirals for HIV prophylaxis. PLoS One (2013) 0.81